Inocencio Galindo is a Senior Partner at Morgan & Morgan Legal and heads the Mining & Natural Resources, Project Development & Public Procurement, and Corporate Investigations, Compliance & Ethics practice groups. Inocencio is also highly recognized in the areas of Corporate & Commercial Law; Banking & Finance; and Mergers & Acquisitions.

Prior to joining the Firm, Inocencio was an Associate at a major international law firm. He has over 25 years of experience and he has played a significant role in the development and financing of large infrastructure projects, such as Line 1, 2 and 3 of the Metro of Panama, the public transportation system Metro Bus, road projects including toll roads, electricity generation, potable water, and sanitation, among others. He has also served as external legal advisor of Minera Panamá, S.A. for over two decades and led the legal team in negotiating a Refreshed Concession Agreement with the Government of Panama for the Cobre Panamá project, which represents an investment of over US$10 billion, making it the largest private investment in Panama's history. Inocencio has also led legal teams in some of the major mergers and acquisitions that have taken place in the Republic of Panama, spanning industries such as banking, insurance, mining, beverages, electricity, automotive, cement, among others. He also possesses extensive experience in negotiation, mediation, and arbitration related to the projects he advices in.

After holding other prominent positions within the organization, Inocencio was elected President of the Board of Directors of the Chamber of Commerce, Industries, and Agriculture of Panama for the 2017-2018 period (the Chamber of Commerce is the most important association of the private sector in Panama with a membership of over 1700 companies); he served as Secretary of the Board of Directors of the National Council of the Private Enterprise (CONEP) for the period 2018-2019, and he is a board member in companies from the banking, construction and related services, as well as pharmaceutical and consumer product distribution industries.